Oxygen free radical involvement in acute lung injury induced by H5N1 virus in mice

Influenza and other Respiratory Viruses

Volumn 7, Issue 6, 2013, Pages 945-953

  He, Guimei ^a,b   Dong, Changgui ^a   Luan, Zhihua ^a,c   Mcallan, Bronwyn M ^d   Xu, Tong ^e   Zhao, Lihong ^a   Qiao, Jian ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c Panjin Animal Disease Control Center   (China)

^d UNIVERSITY OF SYDNEY   (Australia)

^e HEBEI NORTH UNIVERSITY   (China)

Author keywords

Acute lung injury; H5N1 avian influenza A virus; Oxygen free radical; Superoxide

Indexed keywords

LAURIC ACID; OXYGEN RADICAL; SUPEROXIDE DISMUTASE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFLUENZA A (H5N1); INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; LUNG EDEMA; LUNG INFECTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TISSUE CULTURE; VIRUS ETIOLOGY;

ACUTE LUNG INJURY; H5N1 AVIAN INFLUENZA A VIRUS; OXYGEN FREE RADICAL; SUPEROXIDE;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; FREE RADICALS; INFLUENZA A VIRUS, H5N1 SUBTYPE; LUNG; MALE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 84887132810     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12067     Document Type: Article

References (35)

1. WHO. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO, 2003-2011. Available: http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/ (Accessed 12 April 2012).
2. Tran TH, Nguywen TL, Nguyen TD et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179-1188.
3. Chotpitayasunondh T, Ungchusak K, Hanshaoworaku W et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11:201-209.
4. Tran TH, Nguyen TL, Nguyen TD et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179-1188.
5. Szretter KJ, Gangappa S, Lu X et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81:2736-2744.
6. Hers JFP, Mulder J, Masurel N, Kuip LVD, Tyrrell DAJ. Studies on the pathogenesis of influenza virus pneumonia in mice. J Pathol Bacteriol 1962; 83:707-717.
7. Loosli CG, Buckly RD, Hardy JD et al. The pathogenesis of postinfluenzal collapse of the lungs of mice. Trans Assoc Am Physicians 1971; 84:182-189.
8. Raut S, Hurd J, Cureton RJ, Blandford G, Heath RB. The pathogenesis of infections of the mouse caused by virulent and avirulent variations of an influenza virus. J Med Microbiol 1975; 8:127-136.
9. Wyde PR, Couch RB, Mackler BF, Cate TR, Levy BM. Effects of low-and high-passage influenza virus infection virus infection in normal and nude mice. Infect Immun 1977; 15:221-229.
10. Oda T, Akaike T, Hamamoto T et al. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989; 244:974-976.
11. Akaike T, Ando M, Oda T et al. Dependence on O2̇- generation by Xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 1990; 85:739-745.
12. Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Thorpe SR. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant 1996; 11(Suppl. 5):48-53.
13. Suliman HB, Ryan LK, Bishop L, Folz RJ. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am J Physiol Lung Cell Mol Physiol 2001; 280:L69-L78.
14. Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983; 128:552-559.
15. Maeda H, Akaike T. Oxygen free radicals as pathogenic molecules in viral diseases. Proc Soc Exp Biol Med 1991; 198:721-727.
16. Xu T, Qiao J, Zhao LH et al. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Care Med 2006; 174:1011-1017.
17. Gui X, Yang P, Qiu Y, Liu J, Zou G. Studies on the preparation and the stability of SOD modified by lauric acid. Wuhan University J Nat Sci 1998; 3:247-250.
18. Sidwell RW, Huffman JH, Bailey KW et al. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infection in mice. Antimicrob Agents Chemother 1996; 40:2626-2631.
19. Xu T, Qiao J, Zhao LH et al. Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. Eur Respir J 2009; 33:850-860.
20. Cao Y, Guo P, Xu YC, Zhao B. Simultaneous detection of NO and ROS by ESR in biological systems. Methods Enzymol 2005; 396:77-83.
21. Reinke LA, Lai EK, DuBose CM, McCay PB. Reactive free radicals generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc Natl Acad Sci 1987; 84:9223-9227.
22. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34:479-500.
23. Hermann E, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186:407-421.
24. Price GE, Gaszewska-Mastarlarz A, Moskophidis D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol 2000; 74:3996-4003.
25. Reed LJ, Muench H. Simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493-497.
26. Uiprasertkul MP, Puthavathana K, Sangsiriwut P et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005; 11:1036-1041.
27. Slemmer JE, Shacka JJ, Sweeney MI, Weber JT. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem 2008; 15:404-414.
28. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002; 5:291-309.
29. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90:7915-7922.
30. Chan MCW, Cheung CY, Chui WH et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6:135.
31. Monto AS. The role of antivirals in the control of influenza. Vaccine 2003; 21:1796-1800.
32. Guan Y, Chen H. Resistance to anti-influenza agents. Lancet 2005; 366:1139-1140.
33. Fleming DM. Zanamivir in the treatment of influenza. Expert Opin Pharmacother 2003; 4:799-805.
34. Uchide N, Toyoda H. Potential of selected antioxidants for influenza chemotherapy. Anti-Infect Agents Med Chem 2008; 7:73-83.
35. Uchide N, Toyoda H. Future target molecules for influenza treatment. Mini-Rev Med Chem 2008; 8:491-495.